← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. RVTY
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

RVTY logoRevvity, Inc. (RVTY) P/E Ratio History

Historical price-to-earnings valuation from 1990 to 2026

Current P/E
47.5
Overvalued
5Y Avg P/E
34.4
+38% vs avg
PE Percentile
85%
High
PEG Ratio
N/A
N/A
TTM EPS$2.15
Price$98.85
5Y PE Range14.7 - 74.1
Earnings Yield2.10%

Loading P/E history...

RVTY Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
47.5vs34.4
+38%
Premium vs History
vs. Healthcare
47.5vs22.3
+113%
Above Sector
vs. S&P 500
47.5vs25.1
+89%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -14% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, Revvity, Inc. (RVTY) trades at a price-to-earnings ratio of 47.5x, with a stock price of $98.85 and trailing twelve-month earnings per share of $2.15.

The current P/E is 38% above its 5-year average of 34.4x. Over the past five years, RVTY's P/E has ranged from a low of 14.7x to a high of 74.1x, placing the current valuation at the 85th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, RVTY trades at a 113% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

Relative to the broader market, RVTY commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our RVTY DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

RVTY P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
WAT logoWATWaters Corporation
$23B32.66.29+0%
MTD logoMTDMettler-Toledo International Inc.
$27B31.32.82+4%
BIO logoBIOBio-Rad Laboratories, Inc.
$7B9.2Lowest-+143%
HOLX logoHOLXHologic, Inc.
$17B30.5--25%
TMO logoTMOThermo Fisher Scientific Inc.
$176B26.812.67+7%
DHR logoDHRDanaher Corporation
$124B34.9--5%
A logoAAgilent Technologies, Inc.
$34B26.01.76+3%
QGEN logoQGENQiagen N.V.
$7B16.40.37Best+437%Best
ILMN logoILMNIllumina, Inc.
$21B25.56.01+171%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

RVTY Historical P/E Data (1990–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1Sun Apr 05 2026 00:00:00 GM$88.94$2.1042.4x-18%
FY2025 Q4Sun Dec 28 2025 00:00:00 GM$96.75$2.0846.4x-10%
FY2025 Q3Sun Sep 28 2025 00:00:00 GM$84.06$1.9942.1x-18%
FY2025 Q2Sun Jun 29 2025 00:00:00 GM$97.82$2.3641.5x-20%
FY2025 Q1Sun Mar 30 2025 00:00:00 GM$105.62$2.5341.8x-19%
FY2024 Q4Sun Dec 29 2024 00:00:00 GM$111.99$2.4146.5x-10%
FY2024 Q3Sun Sep 29 2024 00:00:00 GM$126.06$2.4651.2x-1%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$104.86$1.7759.1x+14%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$105.00$1.4274.1x+43%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$109.31$5.7019.2x-63%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$110.70$5.9518.6x-64%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$118.79$6.4218.5x-64%

Average P/E for displayed period: 51.7x

Full RVTY Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See RVTY's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is RVTY Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare RVTY vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

RVTY — Frequently Asked Questions

Quick answers to the most common questions about buying RVTY stock.

Is RVTY stock overvalued or undervalued?

RVTY trades at 47.5x P/E, above its 5-year average of 34.4x. The 85th percentile ranking indicates a premium to historical valuation.

How does RVTY's valuation compare to peers?

Revvity, Inc. P/E of 47.5x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is RVTY's PEG ratio?

RVTY PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1990-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

RVTY P/E Ratio History (1990–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.